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Summary
Objectives:  To  illustrate,  via  a  case  report,  how  a  differential  diagnosis  of  amyloidosis  is  to  be
suspected in  case  of  a  nasopharyngeal  mass.
Case  report:  A  59-year-old  woman  presented  with  bilateral  nasal  obstruction  with  associ-
ated episodic  tubal  dysfunction.  Physical  examination  found  a  mass  occupying  the  entire
nasopharynx,  initially  suggestive  of  tumor.
Discussion:  Amyloidosis  was  diagnosed  on  histopathologic  study  of  the  biopsy  and  surgical  speci-
mens. Exploration  for  systemic  disease  proved  negative.  The  localized  amyloidosis  was  managed
conservatively.  At  9  months’  follow-up,  there  was  no  recurrence.
Conclusion:  Localized  amyloidosis,  however  rare,  should  be  considered  as  differential  diagnosis
in any  case  of  nasal  obstruction  with  tubal  dysfunction,  even  if  bilateral.  ENT  physicians  need
to recognize  and  understand  this  pathology  for  adapted  diagnostic  and  treatment  planning.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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myloid  deposits  were  ﬁrst  described  by  Rokitansky  in  1842,
ut  it  was  in  1853  that  Wirchow  designated  such  lesions
s  ‘‘amyloid’’,  wrongly  believing  carbohydrates  to  be  the
rimary  constituent  [1].  Although  pathogenesis  remains
nknown,  the  diagnosis  of  amyloidosis  is  now  well  codiﬁed,
ased  on  histochemical  analysis.  Localized  and  systemic
orms  are  distinguished,  involving  kidney,  heart,  digestive
ract  or  skin.
∗ Corresponding author.
E-mail address: mickael.durbec@hotmail.fr (M. Durbec).
C
A
t
b
c
p
879-7296/$ – see front matter © 2012 Elsevier Masson SAS. All rights re
oi:10.1016/j.anorl.2011.10.010Head  and  neck  locations  are  rare,  the  most  common
eing  laryngeal  or  thyroid  [2].  Nasopharyngeal  amyloidosis
s  exceptional,  with  few  reports  in  the  literature  [3].  We
ere  report  a  case  of  nasopharyngeal  amyloidosis  mimicking
 tumoral  process.
ase report
 59-year-old  woman  presented  with  bilateral  nasal  obstruc-
ion  of  about  1  year’s  evolution.  There  was  associated
ilateral  hearing  loss  with  paroxysmal  tinnitus.  She  did  not
omplain  of  rhinorrhea  or  epistaxis.
Flexible  endoscopy  found  a  polypoid  tumefaction  occu-
ying  almost  the  entire  nasopharynx  with  extension  to  both
served.
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Figure  1  Axial  contrast-enhanced  CT  slice:  homogeneously Figure  2  Axial  T1-weighted  MRI  slice  with  gadolinium  injec-
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A  complete  paraclinical  work-up  is  required  for  posi-
tive  diagnosis  of  amyloidosis  ruling  out  any  systemic  form.enhanced  tissular  mass  invading  the  entire  nasopharynx  and
both fossae  of  Rosenmüller.
Rosenmüller  fossae.  The  mucosal  tumefaction  was  irregular,
ﬁrm  and  pain-free.  Other  ENT  ﬁndings  were  normal,  as  was
the  audiogram.
Cervicothoracic  CT  found  a  mass  occupying  the
entire  nasopharynx,  homogeneously  enhanced  by  contrast
medium,  without  parapharyngeal  or  muscular  extension,
skull  base  extension  or  bone  erosion  (Fig.  1).  On  MRI,  the
mass  was  in  isosignal  on  T1-  and  T2-weighted  images,  homo-
geneously  enhanced  on  gadolinium  injection  (Fig.  2).
Biopsies  were  taken  under  general  anesthesia.  On  micro-
scopic  examination,  hematoxylin  and  eosin  staining  revealed
eosinophil  deposits  in  the  extracellular  matrix.  Congo  red
staining  showed  apple-green  birefringence  under  polarized
light,  suggesting  amyloidosis  (Fig.  3).  Localized  amyloido-
sis  was  then  diagnosed  from  two  biopsies  of  abdominal
fat  and  rectal  mucosa.  Absence  of  amyloid  deposit  in  the
biopsy  samples  ruled  out  any  form  of  systemic  amyloidosis.
Moreover,  a  complete  work-up,  comprising  pulmonary  X-ray,
urine  analysis,  complement  factor  assay,  liver  assessment,
creatinemia  and  urea  assay,  coagulation  assessment  and  pro-
tein  electrophoresis,  was  normal.  Hematologic  studies,  to
rule  out  possible  associated  myeloma  or  plasmacytic  dyscra-
sia,  were  all  negative.  The  whole  amyloid  mass  was  resected
by  CO2 laser  under  general  anesthesia  on  an  endonasal
approach,  without  difﬁculty.  At  5  months’  follow-up,  there
had  been  no  recurrence,  notably  at  the  1-month  endoscopic
check  up.
DiscussionOnset  of  amyloidosis  is  frequently  in  the  4th  to  8th  decades.
It  mainly  affects  males,  with  a  sex  ratio  of  1.5  to  3,
depending  on  the  series.  Etiology  and  exact  pathogenesis
remain  unknown  [2].
F
sion: homogeneous  enhancement  of  the  entire  nasopharynx,
ithout  muscle  involvement.
Amyloidosis  is  deﬁned  by  abnormally  folded  ﬁbrillar  pro-
ein  deposits  with  a  cross-beta  sheet  structure,  a  complex
etwork  of  7.5  to  10  nm  ﬁbrils  showing  apple-green  birefrin-
ence  under  polarized  light  on  Congo  red  staining  [4,5].
Clinically,  amyloidosis  is  classiﬁed  as  systemic  or  local-
zed  [6].  Systemic  forms  are  AL,  AA  and  familial  amyloidosis.
L  amyloidosis  consists  of  amyloid  deposits  without  associ-
ted  disease  other  than  myeloma  or  plasmacytic  dyscrasia.
A  amyloidosis  is  the  most  frequent  form,  with  amyloid
eposit  associated  with  infectious,  inﬂammatory  or  neoplas-
ic  disease.  Familial  amyloidosis  is  a  rare  hereditary  formigure  3  Congo-red  stained  histologic  cross-section  (× 100)
howing apple-green  birefringence  under  polarized  light.
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t  comprises  biopsies  and  histopathologic  exploration  for
myloid  deposits  at  two  sites  distinct  from  the  primitive
ite:  abdominal  fat,  rectal  mucosa,  skin  or  accessory  sali-
ary  glands.  Biological  assessment  of  the  kidneys  and  liver
ith  pulmonary  X-ray  is  required  to  rule  out  renal,  hepatic
r  pulmonary  forms.  Finally,  protein  immunoelectrophore-
is,  myelography  and  complete  coagulation  assessment  are
equired  to  rule  out  any  myeloma  or  plasmacytic  dyscra-
ia.  This  diagnostic  phase  is  important,  as  life  expectancy
nder  systemic  forms  is  poorer  [1].  Treatment  of  AL  amy-
oidosis  consists  in  chemotherapy,  corticosteroids  or  bone
arrow  autograft.  Treatment  of  AA  amyloidosis  is  based  on
radicating  the  underlying  inﬂammatory  pathology.
Head  and  neck  amyloidosis  is  rare  and  most  frequently
ocalized,  with  few  systemic  forms  [8].  Presenting  symptoms
re  mainly  nasal  obstruction,  recurrent  epistaxis,  posterior
hinorrhea  or  otologic  complaints  involving  ear-tube  dys-
unction.  Nasopharyngeal  amyloidosis  usually  consists  of  a
enign  slow-growth  tumor,  but  may  be  locally  aggressive,
nducing  osteolysis  [9].  The  principal  differential  diagnosis
s  malign  tumor,  whence  the  importance  of  histopathologic
iagnosis.  Treatment  of  localized  head-and-neck  amyloido-
is  is  surgical,  using  microinstrumentation  [10]  or  CO2 laser
5].  The  recurrence  rate  approximates  zero,  but  the  extreme
arity  and  slow  evolution  of  this  pathology  make  surveillance
andatory.
onclusion
owever  rare,  nasopharyngeal  amyloidosis  should  be  con-
idered  as  a  differential  diagnosis  in  any  case  of  nasal
bstruction,  posterior  rhinorrhea,  epistaxis  or  ear-tube  dys-
unction.  In  the  present  case,  initial  clinical  and  radiological
vidence  pointed  to  a  malign  tumor.  ENT  physicians  need
o  recognize  and  understand  this  pathology  for  adapted
iagnostic  and  treatment  planning.  In  absence  of  systemic
[M.  Durbec  et  al.
nvolvement,  localized  nasopharyngeal  amyloidosis  should
e  managed  surgically.
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